BIOTEST AG VZ O.N. news, videos and press releases
For more news please use our advanced search feature.
BIOTEST AG VZ O.N. - More news...
BIOTEST AG VZ O.N. - More news...
- EQS-News: Biotest AG opens 12th plasma collection centre in Germany
- EQS-News: Biotest AG increased sales by 32% in the financial year 2023
- EQS-News: Biotest achieves EBIT forecast for 2023
- EQS-News: Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care
- EQS-News: Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
- EQS-News: Biotest AG opens 11th plasma collection centre in Germany
- EQS-News: Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP)
- EQS-News: Biotest’s Trimodulin shows reduced mortality in patients with severe community-acquired pneumonia through rapid normalisation of inflammation
- EQS-News: Biotest increases EBIT to Euro 125.4 million in the first nine months of 2023
- EQS-Adhoc: Biotest AG: Increase of the EBIT guidance
- EQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AG
- EQS-News: Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK
- EQS-News: Biotest AG: Biotest treats first patient with severe community-acquired pneumonia in phase III trial with trimodulin
- EQS-News: Biotest AG: US Food and Drug Administration FDA accepts marketing authorization application for immunoglobulin Yimmugo
- EQS-News: Biotest AG: Biotest treats first shingles patient with Varitect® CP in VARIZOSTA study
- EQS-News: Biotest AG: Biotest Supervisory Board extends Management Board contract of Dr Jörg Schüttrumpf by 5 years
- EQS-News: Biotest AG: Biotest increases EBIT to Euro 19.8 million in the first half of 2023
- EQS-News: Biotest AG: Biotest increases EBIT to Euro 19.8 million
- EQS-News: Biotest AG: Biotest presents gigantic artwork to visualize its sustainability initiatives
- EQS-News: Biotest AG: Annual General Meeting of Biotest AG elects Raimon Grifols Roura to the Supervisory Board
- EQS-News: Biotest AG: Biotest’s Hyperimmunoglobulin Cytotect® CP receives five additional Marketing Authorisations in Europe
- EQS-Adhoc: Biotest AG: Biotest and Grifols further strengthen their cooperation - EBIT forecast 2023 significantly raised
- EQS-News: Biotest AG: Biotest AG opens 12th plasma collection centre in Hungary
- EQS-News: Biotest AG: Biotest AG opens 10th plasma collection centre in Germany
- EQS-News: Biotest AG: Biotest achieves important milestone in phase III trial in acquired fibrinogen deficiency
- EQS-News: Biotest AG: Biotest core business profitable at Euro 60.7 million
- EQS-News: Biotest AG: Biotest donates human albumin for earthquake victims in Turkey
- EQS-News: Biotest AG: Biotest Supervisory Board appoints new Management Board member
- EQS-Adhoc: Biotest AG: Biotest significantly exceeds EBIT guidance 2022
- EQS-News: Biotest AG: First patient treated with Cytotect® CP Biotest in study after heart and lung transplantation
